Nevertheless, the large difference in 3-year OS rates between carriers and non-carriers of the 804C > T SNP in PDCD1 indicates that germline mutations in genes related to the PD-1 axis may have a significant impact on the outcome of patients with cancer after ICIs. Here, PDCD1 is linked to cancer.